Literature DB >> 16878600

Potential role of LPS in the outcome of Helicobacter pylori related diseases.

Aneta Grebowska1, Tomasz Rechciński, Leokadia Bak-Romaniszyn, Elzbieta Czkwianianc, Anthony Moran, Magdalena Druszczyńska, Magdalena Kowalewicz-Kulbat, Agnieszka Owczarek, Michał Dziuba, Maria Krzemińska-Pakuła, Izabela Płaneta-Małecka, Wiesława Rudnicka, Magdalena Chmiela.   

Abstract

In this study we asked a question whether H. pylori LPS with or without LewisXY (Le) determinants as well as LBP (lipopolysaccharide binding protein) and sCD 14 molecules recognizing bacterial LPS may be involved in atherogenesis. Sera from 57 patients with coronary heart disease (CHD), 27 H. pylori infected dyspeptic patients-H.p.(+) and 49 healthy controls (HC) were tested for IgM and IgG to H. pylori LPS expressing LeX (LPS LeX) or LeXY (LPS LeXY) determinants and to a glycine acid extract (GE). Immune complexes (ICs) of Lewis antigens and specific IgM or IgG were also determined. The prevalence of anti-GE IgG and IgA was significantly higher in CHD as compared to HC and the same as in the H.p.(+) group. The highest levels of anti-GE IgG were detected only for CHD group. CHD patients showed upregulation of IgG to LPS LeX and LeXY. In contrast, an upregulation of IgM to such LPSs was found for healthy subjects. The levels ofLeY-anti-LeY IgG ICs were higher in CHD patients than in healthy controls similarly to the levels of LBP. There was no difference in sCD14 concentration between CHD and HC groups. The results obtained in this study indicate that H. pylori infections may be the risk factors of atherosclerosis due to: 1) an enhanced humoral response to H. pylori surface antigens, 2) a host predisposition to respond to Lewis determinants present in H. pylori LPS by IgG, 3) increased levels of serum LBP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878600

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  6 in total

Review 1.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

Review 2.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease.

Authors:  Weronika Gonciarz; Agata Tomaszewska; Agnieszka Krupa; Tomasz Rechciński; Maciej Chałubiński; Marlena Broncel; Magdalena Chmiela
Journal:  J Clin Med       Date:  2022-05-01       Impact factor: 4.964

4.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 5.  Relationship Between Helicobacter pylori Infection and Arteriosclerosis.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Jumpei Yamashita; Takahiro Yoshikawa; Akio Namikawa; Rei Isshiki; Hiroko Takahashi; Yuko Shibuya
Journal:  Int J Gen Med       Date:  2021-04-23

6.  Helicobacter pylori Infection Acts Synergistically with a High-Fat Diet in the Development of a Proinflammatory and Potentially Proatherogenic Endothelial Cell Environment in an Experimental Model.

Authors:  Agnieszka Krupa; Weronika Gonciarz; Paulina Rusek-Wala; Tomasz Rechciński; Adrian Gajewski; Zuzanna Samsel; Anna Dziuba; Agnieszka Śmiech; Magdalena Chmiela
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.